Analyst Ratings for [HCP] HCP, Inc.

9/3/24	Resumed	Neutral	X
HCP HashiCorp Citigroup
$35
4/24/24	Downgrades	Buy Neutral	X
HCP HashiCorp BTIG Research
3/19/24	Initiated	Sector Weight	X
HCP HashiCorp KeyBanc Capital Markets
3/12/24	Upgrades	Sec Perform Sec Outperform	X
HCP HashiCorp Scotiabank
$31
2/26/24	Upgrades	Eq-Weight Overweight	X
HCP HashiCorp Morgan Stanley
$23 $30
12/8/23	Reiterated	Buy	X
HCP HashiCorp Needham
$36 $27
12/8/23	Downgrades	Outperform Mkt Perform	X
HCP HashiCorp TD Cowen
$28 $23
6/8/23	Downgrades	Buy Neutral	X
HCP HashiCorp BofA Securities
3/23/23	Initiated	Buy	X
HCP HashiCorp BTIG Research
$37
3/6/23	Upgrades	Hold Buy	X
HCP HashiCorp Needham
$39
2/24/23	Initiated	Sector Perform	X
HCP HashiCorp Scotiabank
$34
2/13/23	Initiated	Outperform	X
HCP HashiCorp MoffettNathanson
$43
9/30/22	Initiated	Hold	X
HCP HashiCorp Needham
9/30/22	Initiated	Buy	X
HCP HashiCorp Truist
$40
4/12/22	Initiated	Neutral	X
HCP HashiCorp Piper Sandler
$59
1/4/22	Initiated	Neutral	X
HCP HashiCorp Citigroup
$100
1/3/22	Initiated	Buy	X
HCP HashiCorp BofA Securities
$102
1/3/22	Initiated	Outperform	X
HCP HashiCorp Cowen
$105
1/3/22	Initiated	Neutral	X
HCP HashiCorp Goldman
$90
1/3/22	Initiated	Mkt Outperform	X
HCP HashiCorp JMP Securities
$110
1/3/22	Initiated	Neutral	X
HCP HashiCorp JP Morgan
$100
1/3/22	Initiated	Sector Weight	X
HCP HashiCorp KeyBanc Capital Markets
1/3/22	Initiated	Equal-Weight	X
HCP HashiCorp Morgan Stanley
$90
1/3/22	Initiated	Outperform	X
HCP HashiCorp Oppenheimer
$110
1/3/22	Initiated	Buy	X
HCP HashiCorp Stifel
$100
1/3/22	Initiated	Outperform	X
HCP HashiCorp William Blair
1/3/22	Initiated	Outperform	X
HCP HashiCorp Wolfe Research
$105
6/13/19	Upgrades	Mkt Perform Outperform	X
HCP HCP Raymond James
1/7/19	Upgrades	Neutral Outperform	X
HCP HCP Robert W. Baird
12/20/18	Upgrades	Sec Weight Overweight	X
HCP HCP KeyBanc Capital Mkts
11/2/18	Upgrades	Sec Perform Outperform	X
HCP HCP RBC Capital Mkts
10/5/18	Downgrades	Overweight Neutral	X
HCP HCP JP Morgan
9/28/18	Upgrades	Neutral Overweight	X
HCP HCP Cantor Fitzgerald
9/10/18	Upgrades	Underperform In-line	X
HCP HCP Evercore ISI
8/6/18	Reiterated	Buy	X
HCP HCP Stifel
$27 $28
7/24/18	Initiated	Equal Weight	X
HCP HCP CapitalOne
5/21/18	Downgrades	In-line Underperform	X
HCP HCP Evercore ISI
5/21/18	Downgrades	Outperform Mkt Perform	X
HCP HCP Raymond James
3/20/18	Reiterated	Market Perform	X
HCP HCP Wells Fargo
$31 $27
3/8/18	Upgrades	Neutral Buy	X
HCP HCP BofA/Merrill
2/14/18	Reiterated	Buy	X
HCP HCP Stifel
$29 $27

HCP HCP, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

HCP, Inc. is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company's segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities. Its Life science properties contain laboratory and office space for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations. Its Medical office buildings contain physicians' offices and examination rooms, and may include pharmacies, hospital ancillary service space and outpatient services. As of December 31, 2016, it had interests in and managed 15 hospitals, 61 care homes in the United Kingdom and five post-acute/skilled nursing facilities.